IKS

Inventurus Knowledge Solutions share price & financials

Price
₹1,675.2
Market cap
₹30.0k Cr
Sector
Information Technology
Calls analysed
7
Latest concall · Q1 FY27 · call held 06 Aug 2026

Inventurus Knowledge Solutions Limited Q1 FY27

Revenue ₹893 cr +21%EBITDA ₹294 cr EBITDA Margin 33% PAT ₹193 cr +28%

What went well

  • Revenue of ₹893 crores, up 21% YoY (12% in constant currency), demonstrating strong growth.
  • EBITDA margin at 33%, which adjusts to 35% after accounting for one-time acquisition costs of ₹20 crores, reflecting healthy operational performance.
  • PAT grew 28% YoY to ₹193 crores, and EPS grew a healthy 30% YoY.

What to watch

  • One-time exceptional costs of approximately ₹20 crores associated with the TruBridge acquisition impacted reported EBITDA.
  • TruBridge's annualized revenue base was reset from $340 million to $300 million due to changes in revenue recognition, elimination of unprofitable services, and customer discounts.
Read the full call →

What Inventurus Knowledge Solutions Limited does

IKS Health provides technology-enabled revenue cycle management, clinical documentation and care-management services to hospitals, health systems and physician groups across the United States, positioning itself as a combined 'system of action' platform layered on top of clients' electronic health records. It handles the pre-visit, during-visit, post-visit and between-visit workflow for clinicians - scheduling, patient financial clearance, ambient clinical documentation, medical coding, billing, denial prevention and inbox/care management - through a mix of AI/GenAI tools and dedicated clinical, coding and technology staff operating out of global delivery centers. It also supports inpatient/acute settings with clinical documentation, coding, revenue optimization and discharge support, and offers value-based-care solutions for organizations managing risk-based contracts. Revenue is earned on a percentage-of-collections basis or a per-physician-per-month SaaS-based pricing model.

Segments

  • Revenue Optimization
  • Clinical Support
  • Value-Based Care
Healthcare organization clients
700+
Clinicians served
150,000+
Global delivery centers
7
Offices worldwide
17 offices across 4 countries and 3 continents
India offices
12 offices across 7 cities
Top-5 client relationship tenure
8.57 years average
Founded 2006Headquarters Navi Mumbai, Maharashtra, IndiaEmployees 12,661 (FY2024-25 (Annual Report) Company website

Guidance record · Q1 FY27

what the last two calls moved 14 tracked 3 delivered 5 missed 6 open
  • Consolidated EBITDA Margin delivered said Q3 FY25 Promised: early to mid-30s consolidated EBITDA margins perhaps over the next 18 to 24 months. Q1 FY27: Legacy IKS business reported 33% EBITDA margin, adjusted to 35% for one-time costs, continuing to meet the 'mid-30s' target. This promise is now superseded by the new combined entity margin guidance.
  • Net Debt missed said Q3 FY25 Promised: get debt free sometime next fiscal [FY26]. Q1 FY27: Promise remains missed and has been superseded by the new post-acquisition deleveraging target (`net-debt-zero-post-acquisition`).
  • Revenue Growth on track said Q3 FY25 Promised: well north of that 12% that the outsourced TAM is growing at. Q1 FY27: Reported 21% YoY growth (12% in constant currency). Management reiterated a '12%-plus growth aspiration' for the legacy IKS book. While 12% CC meets the revised aspiration, it is not 'well north' of the original target. Still considered on track due to strong reported growth.

All 14 tracked — every revision, and every one management stopped mentioning.

Open the guidance ledger

Quarterly results

Q1 FY27: revenue up 48.9%, net profit up 44.2% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue240 241 290 319 356 +48%404 +68%413 +42%475 +49%
EBITDA116 103 129 150 178 +53%196 +90%212 +64%219 +46%
Net profit92 83 100 113 138 +50%146 +76%169 +69%163 +44%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance +13.3% 1Y

₹1.4k₹1.6k₹1.8kSept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Q2 FY26 — 6 Nov 2025Q3 FY26 — 5 Feb 2026Q3 FY26 — 29 Apr 2026Q1 FY27 — 6 Aug 2026

1Y: ₹1,536.2 on 10 Sept 2025 → ₹1,740.6. High ₹1,928.1 (10 Jul 2026), low ₹1,274.9 (23 Mar 2026).

How the price took the results

close before → close after

Q1 FY27
−6.1%
6 Aug
Q3 FY26
+5.9%
5 Feb
Q2 FY26
+0.1%
6 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Financials, as filed

Revenue grew 53.5% a year over 1 year, FY25 to FY26. Operating margin widened to 49.3%.

Year endingFY25FY26
Revenue₹972 Cr₹1.5k Cr
Operating profit₹427 Cr₹736 Cr
Operating margin43.9%49.3%
Interest₹11 Cr₹12 Cr
Depreciation₹28 Cr₹37 Cr
Net profit₹332 Cr₹566 Cr
Net margin34.2%37.9%
ROCE35.0%44.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹8 Cr₹17 Cr₹17 Cr₹17 Cr₹17 Cr₹17 Cr
Reserves₹368 Cr₹501 Cr₹622 Cr₹811 Cr₹2.2k Cr₹1.8k Cr
Borrowings₹62 Cr₹53 Cr₹43 Cr₹227 Cr₹766 Cr₹110 Cr
Other liabilities₹62 Cr₹133 Cr₹154 Cr₹101 Cr₹600 Cr₹265 Cr
Total liabilities₹500 Cr₹704 Cr₹836 Cr₹1.2k Cr₹3.6k Cr₹2.2k Cr
Fixed assets₹72 Cr₹63 Cr₹49 Cr₹116 Cr₹1.9k Cr₹1.5k Cr
Capital work in progress₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹2 Cr₹0 Cr
Investments₹16 Cr₹16 Cr₹19 Cr₹473 Cr₹361 Cr₹10 Cr
Other assets₹412 Cr₹624 Cr₹767 Cr₹567 Cr₹1.4k Cr₹653 Cr
Total assets₹500 Cr₹704 Cr₹836 Cr₹1.2k Cr₹3.6k Cr₹2.2k Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, the public trimmed −4.33 pp while DIIs added +3.17 pp. The shareholder count grew 6% to 63,025.

Promoters
63.7%
FIIs
8.0%
DIIs
7.5%
Public
18.6%
Others
2.2%

Since Jun 2025

  • Public −4.33 pp
  • DIIs +3.17 pp
  • FIIs +1.51 pp

How it drifted, 7 quarters

Over this window the public fell from 23.5% to 18.6% — −5.0 pp.

Dec '24Sep '25Jun '26

Ownership split by quarter, oldest first. Dec '24: Promoters 63.7%, FIIs 5.5%, DIIs 4.5%, Public 23.5%, Others 2.9%.Mar '25: Promoters 63.7%, FIIs 5.4%, DIIs 4.0%, Public 24.3%, Others 2.6%.Jun '25: Promoters 63.7%, FIIs 6.5%, DIIs 4.3%, Public 22.9%, Others 2.6%.Sep '25: Promoters 63.7%, FIIs 7.0%, DIIs 4.9%, Public 21.9%, Others 2.5%.Dec '25: Promoters 63.7%, FIIs 7.6%, DIIs 6.1%, Public 20.3%, Others 2.4%.Mar '26: Promoters 63.7%, FIIs 8.2%, DIIs 6.4%, Public 19.4%, Others 2.3%.Jun '26: Promoters 63.7%, FIIs 8.0%, DIIs 7.5%, Public 18.6%, Others 2.2%.

Who was buying across the market this quarter →

Who bought this quarter

since Mar 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 0 holders trimming and 0 off the list — both are in the register beside this.

Who is on the register

Named in the Jun 2026 filing

Every holder of Inventurus Knowledge Solutions Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Aryaman Jhunjhunwala Discretionary Trust 16.37%unchanged
Nistha Jhunjhunwala Discretionary Trust 16.37%unchanged
Aryavir Jhunjhunwala Discretionary Trust 16.37%unchanged
Sachin Gupta 10.23%unchanged
Government Pension Fund Global Sovereign2.97%unchanged
Joseph Charles Benardello 2.55%unchanged
Ashwini Gupta 2.06%unchanged
Ashra Family Trust 1.84%unchanged
3p India Equity Fund 1 AIF1.04%newly disclosed
Rekha Jhunjhunwala 0.23%unchanged
Rajeshkumar Radheshyam Jhunjhunwala 0.20%unchanged
Rajeev Purshottamdas Gupta 0.03%unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Mutual funds in IKS

Filings to Aug 2026

0 new, 4 added, 1 trimmed, 0 sold out — net +0.01 L shares (+1.1%).

Held by funds
₹23 Cr
5 schemes
Biggest holder
Nippon India Nifty Smallcap 250 Index Fund
₹14 Cr · 0.4% of that fund
SchemeHoldingLast month
Nippon India Nifty Smallcap 250 Index Fund Nippon India Mutual Fund₹14 Cr+0.01 L
SBI Nifty Smallcap 250 Index Fund SBI Mutual Fund₹7 Cr+0.00 L
Nippon India Nifty 500 Equal Weight Index Fund Nippon India Mutual Fund₹1 Cr+0.00 L
SBI Nifty 500 Index Fund SBI Mutual Fund₹0 Cr−0.00 L
SBI Nifty Small Cap 250 ETF SBI Mutual Fund₹0 Cr+0.00 L

HDFC, Nippon India and SBI schemes, from their monthly disclosures. Changes are counted in shares, so a price move never looks like buying or selling.

Mutual funds Aug 2026

4 added, 1 trimmed — net +1,467 shares (+1.1%)

Funds are sitting on
+8%
vs est. average cost
Held by funds
₹23 Cr
5 schemes · ≈ 0.07% of the company
Biggest holder
Nippon India Nifty Smallcap 250 Index Fund
₹14 Cr · 0.4% of that fund

Shares held by these funds −72%

Dec '24 1.30 L shares Jul '26

What the price assumes

Attractive

To justify its price of ₹1741, this stock must grow earnings at 29% every year for 7 years. Our analysis caps realistic growth at ~71%. At that growth it is worth ₹10868 — upside of 524%.

Growth the price implies
29.2% a year
for 7 years, fading to 4%
It has actually compounded at
70.5% a year
net profit, FY25–FY26 · EPS 70.7%
The gap
-0.4 pp
524% downside if it only repeats history
Price today ₹1,740.6 Value at the reference growth ₹10,867.92

Change the assumptions yourself →

All earnings calls (6)

Read the Q1 FY27 call →

Learn to analyse Inventurus Knowledge Solutions Limited

Guides on how to read this kind of business and the numbers that matter.